A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort.

OBJECT In this paper, the authors' aim was to examine reasons underpinning decisions to undergo, or alternatively forgo, a second-sided deep brain stimulation (DBS) implantation in patients with Parkinson disease (PD). METHODS Fifty-two patients with Parkinson disease (PD) were randomized to receive DBS to the subthalamic nucleus or globus pallidus internus (GPi) as part of the COMPARE trial. Forty-four patients had complete data sets. All patients were offered a choice at 6 months after unilateral implantation whether to receive a contralateral DBS implant. All patients had advanced PD. The mean patient age was 59.8 years (range 43-76 years), and the mean duration of disease was 12.2 years (range 5-21 years). The mean baseline Unified Parkinson's Disease Rating Scale (UPDRS)-III motor score was 42.7. The main outcome measures used in this study were the UPDRS-III Motor Scale and the UPDRS-IV Dyskinesia Scale. RESULTS Twenty-one (48%) of the 44 patients in the cohort did not undergo bilateral implantation and have been successfully treated for an average of 3.5 years; of these, 14 (67%) had a GPi target. The most common reason for adding a second side was inadequacy to address motor symptoms. Patient satisfaction with motor outcomes after unilateral DBS implantation was the most common reason for not undergoing bilateral implantation. Those who chose a second DBS procedure had significantly higher baseline UPDRS-III motor and ipsilateral UPDRS-III scores, and a significantly lower asymmetrical index. The logistic regression analysis revealed that the odds of proceeding to bilateral DBS was 5.2 times higher for STN than for GPi DBS. For every 1% increase in asymmetry, the odds of bilateral DBS decreased [corrected] by 0.96. CONCLUSIONS Unilateral DBS is an effective treatment for a subset of patients with PD. Baseline asymmetry is an important factor in the effectiveness and decision-making process between unilateral and bilateral DBS. Patients with GPi DBS in this cohort were more likely to choose to remain with unilateral implantation.

[1]  D. Bowers,et al.  Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus , 2009, Journal of Neurology.

[2]  M. Okun,et al.  The “Chair Test” to Aid in the Diagnosis of Psychogenic Gait Disorders , 2007, The neurologist.

[3]  N. Van Blercom,et al.  Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[4]  F. Horak,et al.  Comparison between subthalamic nucleus and globus pallidus internus stimulation for postural performance in Parkinson's disease. , 2004, Gait & posture.

[5]  A. Benabid,et al.  Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  S. Chung,et al.  Bilateral Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation in Advanced Parkinson’s Disease , 2006, European Neurology.

[7]  J. Mink,et al.  Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[8]  J. Gracies,et al.  Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. , 2004, Journal of neurosurgery.

[9]  J. Mink,et al.  Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in parkinson disease , 2008, Experimental Neurology.

[10]  C. Hass,et al.  Are two leads always better than one: An emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease , 2008, Experimental Neurology.

[11]  A. Lozano,et al.  Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation , 1999, Neurology.

[12]  A. Shumway-cook,et al.  Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[13]  D. Bowers,et al.  Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial , 2009, Annals of neurology.

[14]  B. Guthrie,et al.  BILATERAL EFFECTS OF UNILATERAL SUBTHALAMIC DEEP BRAIN STIMULATION ON PARKINSON'S DISEASE AT 1 YEAR , 2009, Neurosurgery.

[15]  B. Kall,et al.  Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. , 2007, Journal of neurosurgery.

[16]  S. Tabbal,et al.  Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease , 2008, Experimental Neurology.

[17]  M. Okun,et al.  Pearls in Patient Selection for Deep Brain Stimulation , 2007, The neurologist.